PharmNovo appoints Alexander Dahlquist as new CFO
The Swedish pharmaceutical company PharmNovo, currently at the clinical stage of pioneering a novel solution for neuropathic pain treatment, is pleased to announce the appointment of Alexander Dahlquist as the new CFO. Alexander Dahlquist will play a significant role in supporting the company's journey ahead.Alexander Dahlquist succeeds Tommy Nilsson, who resigned this summer. "We extend our heartfelt gratitude to Tommy Nilsson for his dedicated service and valuable contributions," says Per von Mentzer, CEO of PharmNovo. Alexander Dahlquist assumed the role of CFO in August and will